UNSPSC 41202052: Rhinovirus serological reagents

In this classification, Rhinovirus serological reagents are devices used in test to identify specific Rhinovirus antibodies in serum. US FDA regulates Rhinovirus serological reagents under 21 CFR 866.3490 and under FDA product code GQE.

UNSPSC 41202052 Rhinovirus serological reagents is a Commodity code that in recent state and local practice encompasses HIV, Hepatitis, and Syphilis testing kits and reagents—not rhinovirus-specific products. State and local health departments, criminal justice agencies, and public universities are procuring rapid diagnostic test kits, fourth-generation combination screening assays, confirmatory reagents, calibrators, and controls for high-volume automated and manual laboratory testing. The Illinois Department of Public Health has posted multiple solicitations for Abbott-manufactured HIV and Syphilis reagents and instrumentation (both competitive and emergency sole-source); Collin County Community Supervision and Corrections Department is seeking offender drug-testing services with immunoassay screening and LC/MS/MS confirmation; the City of Austin is bidding rapid HIV test kits for the Austin Public Health Program; and the University of Houston sought blood chemistry reagents and diagnostic testing services for its Student Health Center. Issuing bodies include state health departments, county supervision and corrections agencies, city health departments, and university health centers. Recent activity centers in Texas, Illinois, and Florida, with additional scattered activity in other states.

The Illinois Department of Public Health Division of Laboratories posted an IFB (26482DPHOFCDIB50489) in February 2026 due March 16, 2026, for HIV, Syphilis, and Hepatitis screening assays and fully automated instrumentation across a five-year term with up to five renewal years, requiring FDA 510(K) approval and estimated annual volumes of 13,200 HIV tests, 11,000 Syphilis tests, 3,300 Hepatitis B tests, and 3,000 Hepatitis C tests. Collin County's RFP 2026-327, posted July 9, 2026, due July 23, 2026, seeks offender specimen collection and drug testing services with approximately 25,031 annual tests (immunoassay screening with LC/MS/MS or GC/MS confirmation) across two locations in Plano and McKinney, estimated contract value $600,000 over two years with three optional one-year renewals. The code shows steady recent activity but with significant mission-scope mismatch: the UNSPSC taxonomy labels this a rhinovirus code, yet all posted opportunities target HIV, Hepatitis, Syphilis, and drug-testing assays. Vendors should verify code alignment with specific health department procurement staff before pursuing opportunities tagged under this designation.